Increased risk of inflammatory bowel disease associated with oral contraceptive use.
Research on inflammatory bowel disease risk among oral contraceptive users has reached conflicting conclusions.
This population-based case-control study evaluated the effects of oral contraceptive use on ulcerative colitis and Crohn's disease risk.
Cases were women enrollees, aged 15-68 years, of Group Health Cooperative of Puget Sound (a prepaid health plan based in western Washington State) who had ulcerative colitis (n=211) or Crohn's disease (n=91).
Age-matched controls were randomly selected from the health plan enrollment file.
An in-person interview obtained information about lifetime contraceptive use.
Conditional logistic regression analysis was used to estimate relative risks and 95% confidence intervals for disease.
Mots-clés Pascal : Entérite Crohn, Rectocolite ulcérohémorragique, Epidémiologie, Toxicité, Contraceptif, Voie orale, Homme, Femelle, Washington, Etats Unis, Amérique du Nord, Amérique, Appareil digestif pathologie, Intestin pathologie, Maladie inflammatoire
Mots-clés Pascal anglais : Crohn disease, Ulcerative colitis, Epidemiology, Toxicity, Contraceptive, Oral administration, Human, Female, Washington, United States, North America, America, Digestive diseases, Intestinal disease, Inflammatory disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0624945
Code Inist : 002B13B03. Création : 09/06/1995.